CH BIOTECH SER News

China Biotech Services (8037): Performance growth remained strong in the second quarter of '22

招商證券國際Aug 17, 2022 14:44

China Merchants Securities International: China Biotech Services saw strong revenue growth in the first quarter of '22, consolidating the company's leading position in testing in Hong Kong

招商證券國際May 14, 2022 12:00

China Biotechnology Service (08037, HK): Relying on the precision testing business to contribute to stable cash flow to help incubate the long-term development of the precision treatment business

第一上海研究部Apr 22, 2022 11:51

China Biotech Service (8037.HK): The first CAR-T has been approved for marketing, and the blue ocean in the field of cell therapy is in sight

招商證券(香港)Jul 2, 2021 00:00

China Biotechnology Services (8037.HK): net profit in the third quarter turns to focus on recent R & D progress

招商證券(香港)Nov 20, 2020 00:00

China Biotechnology Service (08037) focuses on accurate biotechnology and will submit 3 applications for clinical trials of new drugs this year.

招商證券Sep 23, 2020 15:21

China Biotechnology Service (08037.HK): Focusing on precision biotechnology is about to set sail

招商證券(香港)Sep 21, 2020 00:00